USPTO serial 79347817
COLLINK.3D
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 23, 2024
- Examiner
- YOUNG, THOMAS PAUL
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with COLLINK.3D?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey A. Smith
Jeffrey A. Smith Millen, White, Zelano & Branigan, P.C.2200 Clarendon BoulevardSuite 1400Arlington, VA 22201Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in pharmaceutical, medical, cosmetics, veterinary and aesthetic industries; chemicals for use in organ transplantation, namely, chemicals for the manufacture of 3D printed scaffolds, tissues and organs, not for medical purposes; bio-chemicals for use in pharmaceutical, medical, cosmetics, veterinary and aesthetic industries; bio-chemicals for use in organ transplantation, namely, bio-chemicals for the manufacture of 3D printed scaffolds, tissues and organs, not for medical purposes; biological preparations for use in industry and science, other than for medical, veterinary, cosmetics or aesthetic use; biological preparations for use in cosmetics and aesthetic industry; biological preparations for use in industry, namely, bio-printable materials in the nature of cells and bio-inks being bio-chemicals for use in cosmetics and aesthetic industries, not for medical use or veterinary purposes; biological preparations for use in cell cultures for applications in the field of cosmetics, not for medical or veterinary use | ACTIVE | — |
| 005 | Biological preparations for use in pharmaceutical, medical and veterinary industry, namely, for personalized medicine use in the nature of treatment of autoimmune diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, microbial disorders and diseases, fungal disorders and diseases, inflammatory disorders and diseases, vaginal and rectal disorders and diseases, ear and eye disorders, orthopedic diseases and disorders, central and peripheral nervous system diseases and disorders, endocrine system diseases and disorders, neurodegenerative diseases and disorders, nasal pharyngeal diseases and disorder, cancer, infectious diseases and viral infections; bioadhesives, namely, medical adhesives intended for closure of wounds and gaps and for other medical fixing, namely, binding internal tissue; bio-printed materials for use in organ transplantation, namely, biological soft, hard, skin and bone tissue grafts and cultures, implantable scaffolds comprised of living tissue or cells, organ implants comprised of living tissue or cells, intended for subsequent implantation, and bio-inks comprised of living cells which stimulates tissue regeneration and support cell adherence and proliferation for medical use; biological implants, namely, biological soft and hard human connective tissue intended for subsequent implantation and organ implants comprised of living tissue or cells, intended for subsequent implantation; biological preparations for use in cell culture applications in the fields of pharmaceutical, medical, veterinary and aesthetic medicine use, namely, cell culture media for cultivating animal or human tissue or cells | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 25, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 4, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 4, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 23, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 23, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 23, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 7, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 7, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 7, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 17, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 17, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 17, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 1, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 13, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 13, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 13, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 13, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 13, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 24, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 24, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 13, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 13, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 13, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 9, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 8, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 29, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 8, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 8, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 12, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 11, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 11, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 23, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 19, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 18, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |